PAL S. EVALUATION OF CYSTATIN C AS AN EARLY MARKER OF RENAL IMPAIRMENT IN DIABETIC AND HYPERLIPIDAEMIC PATIENTS. World Research Journal of Medical Science. 2013; 1(1):13-17.